© 2017 All Rights Reserved
Aphelion Pharmaceuticals Inc.
is in the process of building it’s facility to become a Licensed Provider of cannabinoid-based medical products pursuant
to the Health Canada ‘s
Access to Cannabis for Medical Purposes Regulations (ACMPR).
Aphelion plans to develop a portfolio of cannabinoid-based products for medical applications.
Regulatory applications are underway for the approval to produce and supply these products.